TABLE 2.
Antibiotic susceptibilities of A. baumannii clinical isolates
Antibiotica | MIC (μg/ml)b
|
||
---|---|---|---|
FM0209680 | FM0300106 | FM0301433 | |
Ampicillin | >16 | >16 | >16 |
Amoxicillin-CLA | 8/4 | 8/4 | 16/8 |
Piperacillin | >64 | >64 | >64 |
Cefazolin | >16 | >16 | >16 |
Cefotiam | >16 | >16 | >16 |
Cefoperazon-SUL | ≤16/8 | ≤16/8 | 32/16 |
Cefotaxime | >128 | >128 | >128 |
Cefotaxime-CLA | 2 | 8 | 4 |
Ceftazidime | 8 | 8 | 8 |
Ceftazidime-CLA | 1 | 4 | 2 |
Ceftriaxone | >64 | >64 | >64 |
Cefpirome | >16 | >16 | >16 |
Cefepime | >32 | >32 | >32 |
Cefozopran | >16 | >16 | >16 |
Cefaclor | >16 | >16 | >16 |
Cefpodoxime | >64 | >64 | >64 |
Cefoxitin | >32 | >32 | >32 |
Cefmetazole | 32 | 32 | >32 |
Cefotetan | 32 | 32 | 16 |
Flomoxef | 16 | 16 | 16 |
Imipenem | ≤0.5 | ≤0.5 | ≤0.5 |
Meropenem | 1 | 1 | 1 |
Aztreonam | >64 | >64 | >64 |
Gentamicin | >8 | >8 | 2 |
Amikacin | 32 | >32 | 16 |
Minocycline | 4 | 4 | 4 |
Levofloxacin | 4 | 4 | 2 |
Fosfomycin | >16 | >16 | >16 |
CLA, clavulanic acid at a fixed concentration of 4 μg/ml; SUL, sulbactam.
NEG Combo 5J and NEG MIC 5J panels and ESBL plus panel were used for MICs determinations.